About this trial
The hypothesis of the present study is that restoring nasal stimulation alleviates dyspnea and improves respiratory drive. The aim of this study is to compare three non-pharmacological approaches designed to restore nasal stimulation (continuous nasal airflow, nasal sprays, and facial airflow) in tracheotomized patients dependent on mechanical ventilation.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age ≥ 18 years
Tracheostomy and mechanical ventilation
Dyspnea ≥3
Consent to participate
Disqualifiers
Agitation, delirium
Continuous use of sedatives
Patients under law protection
Inmates
Trial design
Single group
Treatments tested in this trial
Baseline
Procedure/Surgerypatient ventilated through the tracheostomy with initial ventilator settings
Installation of high flow humidified air cannula
Procedure/SurgeryInstallation of high flow humidified air cannula with inspired oxygen fraction (FiO2) 21%
Nasal air puffs
Procedure/SurgeryNasal air puffs synchronized with the inspiratory time of the ventilator
propeller fan (FAN)
Procedure/SurgeryStand-alone fan at the bedside directed toward the face of the patient
Treatment groups
Trial outcomes
Primary outcomes
Dyspnea
visual analogical scale
Secondary outcomes
airway occlusion pressure
visual analogical scale
end expiratory occlusion pressure
visual analogical scale
respiratory electromyogram (EMG)
visual analogical scale
tolerance
visual analogical scale
Sponsors and contacts
Click on the lead sponsor to view all of their trials.